Effect of topical compound of erythromycin with zinc acetate versus topical erythromycin on treatment of mild to moderate acne vulgaris
Phase 3
Recruiting
- Conditions
- Acne vulgaris.Acne vulgarisL70.0
- Registration Number
- IRCT20120215009014N397
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 82
Inclusion Criteria
Age of 12 to 75 years,
Mild to moderate acne vulgaris
Exclusion Criteria
Pregnancy or breastfeeding,
Sensitivity to erythromycin or zinc acetate,
History of taking oral isotretinoin during the last 6 months,
History of taking oral estrogen compounds during the last 3 months,
History of using retinoid and antibiotic compounds during the last 1 month,
History of using antimicrobial soap and topical exfoliators during the last 2 weeks,
Chronic skin diseases such as psoriasis, lichen planus, and vitiligo,
Immunodeficiency disorder or using immunosuppressive drugs
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of acne lesions. Timepoint: Before the intervention and 1 and 2 and 3 months after the intervention. Method of measurement: Using the Global Acne Grading System (GAGS).
- Secondary Outcome Measures
Name Time Method